BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...

Systemic Lupus Erythematosus is an autoimmune disease affecting multiple organs. Symptoms include rashes, joint pain, anemia, ...

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...

The autoimmune disorder systemic lupus erythematosus (SLE) involves upregulation of IgD, and studies have shown that anti-IgD antibodies can alleviate the autoimmune disorder rheumatoid arthritis in ...

Which of the statements about the 2025 guideline summary for the treatment of systemic lupus erythematosus are correct?

Autoimmune diseases, including systemic lupus erythematosus (SLE), are more common in women than men, and scientists are still trying to figure out why. One reason may be related to the number of X ...

The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...

Systemic Lupus Erythematosus: Which Drugs and When? Ronald F van Vollenhoven Disclosures Int J Clin Rheumatol. 2014;9 (4):385-394. Short-term Treatment of Active Nonrenal SLE ...

Abstract and Introduction Abstract The occurrence of neuropsychiatric manifestations in systemic lupus erythematosus (NPSLE) represents a diagnostic and therapeutic challenge for patients and ...